These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Visualization of malignant tumors in the abdomen using radiolabelled monoclonal antibodies]. Pateisky N; Philipp K; Burchell J; Skodler W Geburtshilfe Frauenheilkd; 1984 Oct; 44(10):623-6. PubMed ID: 6097499 [TBL] [Abstract][Full Text] [Related]
29. [Immunoscintigraphy of oncologic tumors]. Barzen G Radiol Diagn (Berl); 1990; 31(3):209-20. PubMed ID: 2367627 [TBL] [Abstract][Full Text] [Related]
30. Radioimmunodetection in patients with suspected ovarian cancer. Pateisky N; Philipp K; Skodler WD; Czerwenka K; Hamilton G; Burchell J J Nucl Med; 1985 Dec; 26(12):1369-76. PubMed ID: 4067639 [TBL] [Abstract][Full Text] [Related]
31. Is there a role for (99m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma? Fuster D; Maurel J; Muxí A; Setoain X; Ayuso C; Martín F; Ortega ML; Fuertes S; Pons F Q J Nucl Med; 2003 Jun; 47(2):109-15. PubMed ID: 12865871 [TBL] [Abstract][Full Text] [Related]
32. [Evaluation of the diagnostic usefulness of CA125 immunoscintigraphy for ovarian carcinoma follow-up after treatment: contribution of this technique in Grenoble University Medical Center]. Vuillez JP; Levrot E; Mousseau M; Buffaz PD; Bolla M; Payan R; Comet M; Schaerer R Bull Cancer; 1997 Nov; 84(11):1033-42. PubMed ID: 9536985 [TBL] [Abstract][Full Text] [Related]
33. Immunoscintigraphy in human squamous lung cancer using monoclonal antibodies. Mathieu A; Lumbroso J; Bergmann JF; Bellet D; Caillaud JM; Baldeyrou P; Strugo MC; Bohuon C; Parmentier C Behring Inst Mitt; 1984 May; (74):72-9. PubMed ID: 6383329 [TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibody MAb-170 for immunoscintigraphic detection of ovarian tumors. Alexander C; Villena-Heinsen CE; Schaefer A; Toth L; Schmidt W; Kirsch CM Am J Obstet Gynecol; 1999 Sep; 181(3):513-7. PubMed ID: 10486456 [TBL] [Abstract][Full Text] [Related]
35. Breast cancer imaging with radiolabelled peptide from complementarity-determining region of antitumour antibody. Sivolapenko GB; Douli V; Pectasides D; Skarlos D; Sirmalis G; Hussain R; Cook J; Courtenay-Luck NS; Merkouri E; Konstantinides K Lancet; 1995 Dec 23-30; 346(8991-8992):1662-6. PubMed ID: 8551823 [TBL] [Abstract][Full Text] [Related]
36. OC125 immunoscintigraphy in ovarian carcinoma: a comparison with alternative methods of assessment. Maughan TS; Haylock B; Hayward M; Facey P; Evans WD; Shelley MD; Fish RG; Adams M Clin Oncol (R Coll Radiol); 1990 Jul; 2(4):199-205. PubMed ID: 2261415 [TBL] [Abstract][Full Text] [Related]
37. Immunoscintigraphy in the follow up of patients with ovarian cancer. Gerli M; Palumbo R; Angelini A; Gerli S; Brunelli E; Pupita P; Bonaca S; Spagnolo W Eur J Gynaecol Oncol; 1990; 11(3):203-4. PubMed ID: 2209638 [TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibodies for radioimmunodetection of tumours and for targeting. Baldwin RW; Embleton MJ; Pimm MV Bull Cancer; 1983; 70(2):132-6. PubMed ID: 6575842 [TBL] [Abstract][Full Text] [Related]
39. Radionuclide imaging of epithelial ovarian tumours with 123I-labelled monoclonal antibody (H317) specific for placental-type alkaline phosphatase. Critchley M; Brownless S; Patten M; McLaughlin PJ; Tromans PM; McDicken IW; Johnson PM Clin Radiol; 1986 Mar; 37(2):107-12. PubMed ID: 3698490 [TBL] [Abstract][Full Text] [Related]